
Explaining gene and cell therapy
Illustrations for Oxford BioMedica vector technology and Novartis treatments
Our illustrations for Oxford BioMedica's products targeting Parkinson's and ocular disease, and the Novartis CTL-019 for lymphocytic leukemia explain to investors and wider audiences how their cutting edge technology and treatments work.
photography and illustration










